Hydrogen bonding interactions of covalently bonded fluorine atoms: From crystallographic data to a new angular function in the GRID force field

Journal of Medicinal Chemistry

Volumn 47, Issue 21, 2004, Pages 5114-5125

  Carosati, Emanuele ^a   Sciabola, Simone ^a   Cruciani, Gabriele ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE;

ARTICLE; BINDING SITE; CRYSTALLOGRAPHY; DRUG STRUCTURE; HYDROGEN BOND; LIGAND BINDING; PROTEIN BINDING; PROTEIN DATA BANK; PROTEIN STRUCTURE; STATISTICAL ANALYSIS; STRUCTURE ANALYSIS;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; FLUORINE; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROBABILITY; PROTEIN BINDING; PROTEINS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4744373354     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0498349     Document Type: Article

References (37)

1. MDL Drug Data Report is available from Molecular Design Limited Information Systems, Inc., 14600 Catalina St., San Leandro, CA 94577.
2. Muegge, I.; Heald, S. L.; Brittelli, D. Simple Selection Criteria for Drug-like Chemical Matter. J. Med. Chem. 2001, 44, 1841-1846.
3. 1D Receptor Ligands with Improved Pharmacokinetic Profiles. J. Med. Chem. 1999, 42, 2087-2104.
4. Wu, Y.-J.; Davis, C. D.; Dworetzky, S.; Fitzpatrick, W. C.; Harden, D.; He, H.; Knox, R. J.; Newton, A. E.; Philip, T.; Poison, C.; Sivarao, D. V.; Sun, L.-Q.; Tertyshnikova, S.; Weaver, D.; Yeola, S.; Zoeckler, M.; Sinz, M. W. Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (S)-N-[1-(4-Fluoro-3-morpholin-4-ylphenyl)ethyl]-3-(4- fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition. J. Med. Chem. 2003, 46, 3778-3781.
5. Zamora, I.; Afzelius, L.; Cruciani, G. Predicting Drug Metabolism: A Site of Metabolism Prediction Tool Applied to the Cytochrome P450 2C9. J. Med. Chem. 2003, 46, 2313-2324.
6. 2A Receptor Antagonists. J. Med. Chem. 2001, 44, 1603-1614.
7. Dugar, S.; Yumibe, N.; Clader, J. W.; Vizziano, M.; Huie, K.; Van Heek, M.; Compton, D. S.: Davis Jr. H. R. Metabolism and structure activity data based drug design: discovery of (-) SCH 53079 an analog of the potent cholesterol absorption inhibitor (-) SCH 48461. Biorg. Med. Chem. Lett. 1996, 6, 1271-1274.
8. West, R.; Powell, D. L.; Whatley, L. S.; Lee, M. K. T.; Schleyer, P.von R. The relative strengths of alkyl halides as proton acceptor groups in hydrogen bonding. J. Am. Chem. Soc. 1962, 84, 3221-3222.
9. O'Hagan, D. Rzepa, H. S. Some influences of fluorine in bioorganic chemistry. Chem. Commun. 1997, 645-652.
10. Murray-Rust, P.; Stallings, W. C.; Monti, C. T.; Preston, R. K.; Glusker, J. P. Intermolecular Interactions of the C-F Bond: The Crystallographic Environment of Fluorinated Carboxylic Acids and Related Structures. J. Am. Chem. Soc. 1983, 105, 3206-3214.
11. Brammer, L.; Bruton, E. A.; Sherwood, P. Understanding the Behaviour of Halogens as Hydrogen Bond Acceptors. Cryst. Growth Des. 2001, 1, 277-290.
12. Stainer, T. Hydrogen-bond distances to halide ions and organometallic crystal structures: up-to-date database study. Acta Crystallogr. 1998, B54, 456-563.
13. 3) hydrogen bonding interactions in the solid state. J. Chem. Soc., Perkin Trans. 2 1997, 1999-2001.
14. Allerhand, A.; Scheleyer, P. von R. Halide anions as proton acceptors in hydrogen bonding. J. Am. Chem. Soc. 1983, 85, 1233-1237.
15. Harbell, S. A.; McDaniel, D. H. Strong Hydrogen Bonds. II. The Hydrogen Difluoride Ion. J. Am. Chem. Soc. 1984, 86, 4497-4497.
16. Brammer, L.; Bruton, E. A.; Sherwood, P. Fluoride Ligands exhibit marked departures from the hydrogen bond acceptor of their heavier halogen congeners. New J. Chem. 1999, 23, 965-968.
17. Laurence, C.; Berthelot, M. Observations on the strength of hydrogen bonding. Persp. Drug Discovery Des. 2000, 1, 39-60.
18. Ouvrard, C.; Berthelot, M.; Laurence, C. The first basicity scale of fluoro-, chloro,-, bromo- and iodo-alkanes: some cross-comparison with simple alkyl derivatives of other elements. J. Chem. Soc., Perkin Trans. 2 1999, 1357-1362.
19. Howard, J. A. K.; Hoy, V. J.; O'Hagan, D.; Smith, G. T. How Good is Fluorine as a Hydrogen Bond Acceptor? Tetrahedron 1998, 52, 12613-12622.
20. Allen F. H.; Davies, J. E.; Galloy, J. J.; Johnson, O.; Kennard, O.; Macrae, C. F.; Mitchell, E. M.; Mitchell, G. F.; Smith, J. M.; Watson, D. G. The development of versions 3 and 4 of the Cambridge Structural Database System. J. Chem. Inf. Comput. Sci. 1991, 31, 187-204.
21. Shimoni, L.; Glusker, J. P. The Geometry of Intermolecular Interactions in Some Crystalline Fluorine-Containing Organic Compounds. Struct. Chem. 1994, 5, 383-397.
22. Dunitz, J. D.; Taylor, R. Organic Fluorine Hardly Ever Accepts Hydrogens Bonds. Chem. Eur. J. 1997, 3, 89-98.
23. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
24. http://www.rcsb.org/pdb/
25. Goodford, P. J. A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules. J. Med. Chem. 1985, 28, 849-857.
26. The version 22 of the GRID package is available from Molecular Discovery Ltd., 4, Chandos Street, W1A 3BQ, London, United Kingdom. http://www. moldiscovery.com
27. Thallypally, P. K.; Nangia, A. A Cambridge Structural Database analysis of the C-H⋯Cl interaction: C-H⋯Cl- and C-H⋯Cl-M often behave as hydrogen bonds but C-H⋯Cl-C is generally a van der Waals interaction. Cryst. Eng. Commun. 2001, 3, 114-119.
28. Aakeroy, C. B.; Evans, T. A.; Seddon, K. R.; Palinko, I. The C-H⋯Cl hydrogen bond: does it exist? New. J. Chem. 1999, 23, 145-152.
29. Bondi, A. van der Waals Volumes and Radii. J. Phys. Chem. 1984, 68, 441-451.
30. SYBYL 6.7, Tripos Inc., 1699 South Hanley Rd., St. Louis, Missouri, 63144.
31. Boobbyer, D. N. A.; Goodford, P. J.; McWhinnie, P. M.; Wade, R. C. New Hydrogen-Bond Potentials for Use in Determining Energetically Favorable Binding Sites on Molecules of Known Structure. J. Med. Chem. 1989, 32, 1083-1094.
32. Wade, R. C.; Clark, K. J.; Goodford, P. J. Further Development of Hydrogen Bond Functions for Use in Determining Energetically Favorable Binding Sites on Molecules of Known Structure. 1. Ligand Probe Groups with the Ability to Form Two Hydrogen Bonds. J. Med. Chem. 1993, 36, 140-147.
33. Wade, R. C.; Goodford, P. J. Further Development of Hydrogen Bond Functions for Use in Determining Energetically Favorable Binding Sites on Molecules of Known Structure. 2. Ligand Probe Groups with the Ability to Form More Than Two Hydrogen Bonds. J. Med. Chem. 1993, 36, 148-156.
34. James, M. N. G.; Sielecki, A. R.; Hayakawa, K.; Gelb, M. H. Crystallographic Analysis of Transition State Mimics Bound to Penillopepsin: Difluorostatine- and Difluorostatone-Containing Peptides. Biochemistry 1992, 31, 3872-3886.
35. Takahashi, L. H.; Radhakrishnan, R.; Rosenfield, R. E.; Meyer, Jr. E. F. Crystallographic Analysis of the Inhibition of Porcine Pancreatic Elastase by a Peptidyl Boronic Acid: Structure of a Reaction Intermediate. Biochemistry 1989, 28, 7610-7617.
36. Kroon, J.; Kanters, J. A. Nonlinearity of hydrogen bonds in molecular crystals. Nature 1974, 248, 667-668.
37. Peapus, D. H.; Chiu, H.-J.; Campobasso, N.; Reddick, J. J.; Begley, T. P.; Ealick, S. E. Structural Characterization of the Enzyme-Substrate, Enzyme-Intermediate, and Enzyme-Product Complexes of Thiamin Phosphate Synthase. Biochemistry 2001, 40, 10103-10114.